Adaptive Biotechnologies Corp
ADPT· Nasdaq
Released Feb 14, 2023, after the close
10-K filed Feb 14, 2023, 45 days after period end · 0000950170-23-002792
derived · Computed from the longer spans the company filed.
| Metric | Q4 2022dderived from reported figures | Q4 2021dderived from reported figures | Q4 2020dderived from reported figures | Q4 2019dderived from reported figures |
|---|---|---|---|---|
| Revenue | $55.20M | $37.93M | $30.19M | $24.21M |
| Net Income | -$40.13M |
Adaptive Biotechnologies Corp · CIK 1478320 · Engraved from SEC EDGAR
| -$61.43M |
| -$44.57M |
| -$20.61M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.